This article has been cited by
1Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms
Koulenti, Xu, Mok, Song, Karageorgopoulos, Armaganidis, Lipman, SotiriosTsiodras
2Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
Leama Ajaka,Emily Heil,Sarah Schmalzle
3Total Syntheses and Chemical Biology Studies of Hymeglusin and Fusarilactone A, Novel Circumventors of ß-Lactam Drug Resistance in Methicillin-Resistant Staphylococcus aureus
Masahiro Kanaida,Aoi Kimishima,Shuhei Eguchi,Masato Iwatsuki,Yoshihiro Watanabe,Masako Honsho,Tomoyasu Hirose,Yoshihiko Noguchi,Kenichi Nonaka,Goh Sennari,Hidehito Matsui,Chikara Kaito,Hideaki Hanaki,Yukihiro Asami,Toshiaki Sunazuka
4Prevention and Treatment of Multidrug-Resistant Organisms in End-Stage Renal Disease
John K. Midturi,Sangeetha Ranganath
Advances in Chronic Kidney Disease.2019;26(1)51
5Antimicrobial activity of dalbavancin and comparators against Staphylococcus aureus causing pneumonia in patients with and without cystic fibrosis
Helio S. Sader,Leonard R. Duncan,Rodrigo E. Mendes
International Journal of Infectious Diseases.2021;107(1)69
6Epithelial Lining Fluid and Plasma Concentrations of Dalbavancin in Healthy Adults after a Single 1,500-Milligram Infusion
Urania Rappo,Michael W. Dunne,Sailaja Puttagunta,James S. Baldassarre,Shengfang Su,Daksha Desai-Krieger,Megumi Inoue
Antimicrobial Agents and Chemotherapy.2019;63(11)69
A. M. Morozov,A. N. Sergeev,E. M. Askerov,S. V. Zhukov,N. S. Novikova,M. A. Belyak,E. A. Sobol
Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2021;63(11)69
8Emerging antibacterial and antiviral drugs for treating respiratory tract infections
Marco Mantero,Paola Rogliani,Mario Cazzola,Francesco Blasi,Marta Di Pasquale
Expert Opinion on Emerging Drugs.2018;23(3)185
9Mammary Dysbiosis and Nipple Blebs Treated With Intravenous Daptomycin and Dalbavancin
Katrina B. Mitchell,Anne Eglash,Ethan T. Bamberger
Journal of Human Lactation.2020;36(2)365
10Treatment of osteoarticular, cardiovascular, intravascular-catheter-related and other complicated infections with dalbavancin and oritavancin: A systematic review
Geren Thomas,Andrés F. Henao-Martínez,Carlos Franco-Paredes,Daniel B. Chastain
International Journal of Antimicrobial Agents.2020;56(3)106069
11Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections
Jacqueline T. Bork,Emily L. Heil,Shanna Berry,Eurides Lopes,Rohini Davé,Bruce L. Gilliam,Anthony Amoroso
Infectious Diseases and Therapy.2019;8(2)171
12Successful treatment of methicillin-sensitive Staphylococcus aureus tricuspid-valve endocarditis with dalbavancin as an outpatient in a person who injects drugs: A case report
Aaron Hakim,Hannan Braun,David Thornton,Judith Strymish
International Journal of Infectious Diseases.2020;91(2)202